MakCHS Publications

Found 10 results
Author [ Keyword(Desc)] Title Type Year
Filters: Keyword is Antiretroviral Therapy, Highly Active  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Antiretroviral Therapy, Highly Active
F. Lutwama, Serwadda, R., Mayanja-Kizza, H., Shihab, H. M., Ronald, A., Kamya, M. R., Thomas, D., Johnson, E., Quinn, T. C., Moore, R. D., and Spacek, L. A., Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy., Journal of acquired immune deficiency syndromes (1999), vol. 48, no. 3, pp. 297-303, 2008.
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients., AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
B. Castelnuovo, Byakwaga, H., Menten, J., Schaefer, P., Kamya, M., and Colebunders, R., Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?, AIDS (London, England), vol. 22, no. 2, pp. 269-73, 2008.
D. Cohan, Natureeba, P., Koss, C. A., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Gandhi, M., Clark, T. D., Nzarubara, B., Achan, J., Ruel, T., Kamya, M. R., and Havlir, D. V., Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women., AIDS, vol. 29, no. 2, pp. 183-91, 2015.
J. B. Angel, Hu, Y. - W., Kravcik, S., Tsui, R., Lee, K. H., Barbour, J., Balaskas, E., Branson, B. M., Delwart, E. L., and Grant, R. M., Virological evaluation of the 'Ottawa case' indicates no evidence for HIV-1 superinfection., AIDS (London, England), vol. 18, no. 2, pp. 331-4, 2004.
M. Bwakura-Dangarembizi, Musiime, V., Szubert, A. J., Prendergast, A. J., Gomo, Z. A., Thomason, M. J., Musarurwa, C., Mugyenyi, P., Nahirya, P., Kekitiinwa, A., Gibb, D. M., Walker, A. S., and Nathoo, K., Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy., Pediatr Infect Dis J, vol. 34, no. 2, pp. e23-31, 2015.
R. Colebunders, Moses, K. R., Laurence, J., Shihab, H. M., Semitala, F., Lutwama, F., Bakeera-Kitaka, S., Lynen, L., Spacek, L., Reynolds, S. J., Quinn, T. C., Viner, B., and Mayanja-Kizza, H., A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries., The Lancet infectious diseases, vol. 6, no. 1, pp. 53-9, 2006.
C. Thorne and Newell, M. - L., Are girls more at risk of intrauterine-acquired HIV infection than boys?, AIDS (London, England), vol. 18, no. 2, pp. 344-7, 2004.
E. Nakimuli-Mpungu, Musisi, S., Mpungu, S. K., and Katabira, E., Primary mania versus HIV-related secondary mania in Uganda., The American journal of psychiatry, vol. 163, no. 8, pp. 1349-54; quiz 1480, 2006.
C. L. Cooper and Cameron, W. D., Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infection., AIDS (London, England), vol. 18, no. 2, pp. 337-8, 2004.